Skip to main content

Peer Review reports

From: Efficacy and safety of baricitinib in treatment of systemic lupus erythematosus: a systematic review and meta-analysis

Original Submission
9 Aug 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Sep 2023 Reviewed Reviewer Report - Edsaul Emilio Pérez-Guerrero
18 Sep 2023 Reviewed Reviewer Report - Alberto Muniz Gutierrez
23 Sep 2023 Author responded Author comments - Abdallah R. Allam
Resubmission - Version 3
23 Sep 2023 Submitted Manuscript version 3
24 Sep 2023 Author responded Author comments - Abdallah R. Allam
Resubmission - Version 4
24 Sep 2023 Submitted Manuscript version 4
24 Sep 2023 Author responded Author comments - Abdallah R. Allam
Resubmission - Version 5
24 Sep 2023 Submitted Manuscript version 5
5 Oct 2023 Reviewed Reviewer Report - Edsaul Emilio Pérez-Guerrero
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
10 Oct 2023 Editorially accepted
31 Oct 2023 Article published 10.1186/s41927-023-00363-6

You can find further information about peer review here.

Back to article page